Stem cell therapy has shown to improve left ventricular function in patients with ischemic cardiomyopathy. Serum B type natriuretic peptide (BNP) has been to used to evaluate the neurohormonal status of congestive heart failure symptoms. The goal of this study was to determine if serum BNP levels improved in ischemic cardiomyopathy patients under going stem cell therapy.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The Journal of Heart and Lung Transplantation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.